| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13G · 1 security · passive | ||||||
|
Innate Pharma SA
13G/A
45781K105
|
0% |
6/22/2026
Event 5/29/2026
|
||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.